Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 45 - Medicinal preparations containing active ingredients not provided for in groups
Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020)
10/2014
10/02/2014US20140294900 Flagellin related polypeptides and uses thereof
10/02/2014US20140294898 Macrocyclic inhibitors of the pd-1/pd-l1 and cd80(b7-1)/pd-l1 protein/protein interactions
10/02/2014US20140294897 Potent lna oligonucleotides for the inhibition of hif-1a expression
10/02/2014US20140294875 Leishmania Vaccine Using Sand Fly Salivary Immunogen
10/02/2014US20140294873 Small molecule screen for inhibitors of nfat: ap-1: dna interactions
10/02/2014US20140294856 Combination treatment comprising a hdac6 inhibitor and an akt inhibitor
10/02/2014US20140294851 Cleavable drug conjugates, compositions thereof and methods of use
10/02/2014US20140294842 Assays, Methods and Means
10/02/2014US20140294829 Anti-ngf antibodies for the treatment of various disorders
10/02/2014US20140294827 Fully Human Antibodies that Bind to VEGFR2
10/02/2014US20140294818 Pgam1 inhibitors and methods related thereto
10/02/2014US20140294816 Combination therapy for the treatment of ocular neovascular disorders
10/02/2014US20140294811 Method for predicting risk of hypertension associated with anti-angiogenesis therapy
10/02/2014US20140294808 Treating cancer with hsp90 inhibitory compounds
10/02/2014US20140294806 Methods and compositions for treating cancers having acquired resitance to prior chemotherapeutic and targeted drugs using carboxyamidotriazole orotate
10/02/2014US20140294805 Novel compounds and compositions for the inhibition of nampt
10/02/2014US20140294799 Use of compositions having a low polyamine content in the prevention or treatment of adverse effects linked to cancer treatment
10/02/2014US20140294794 Methods for treating bleeding disorders using a platelet subpopulation
10/02/2014US20140294790 Method of preventing, controlling and ameliorating urinary tract infections and supporting digestive health by using a synergistic cranberry derivative, a d-mannose composition and a proprietary probiotic blend
10/02/2014US20140294788 Methods for enhancing muscle protein synthesis following concurrent training
10/02/2014US20140294769 2',4'-fluoro nucleosides for the treatment of hcv
10/02/2014US20140294767 Method of treating hcv infection with a small molecule chk2 inhibitor
10/02/2014US20140294766 Anti-Infective Agents and Uses Thereof
10/02/2014US20140294765 Lsr antibodies, and uses thereof for treatment of cancer
10/02/2014US20140294764 Compounds and compositions used to epigenetically transform cells and methods related thereto
10/02/2014US20140294763 Peptidomimetic protease inhibitors
10/02/2014US20140294755 Materials and Methods Relating to Stem Cell Mobilization by Multi-Pegylated Granulocyte Colony Stimulating Factor
10/02/2014US20140294753 Novel use of ganodermic acids for treating cancer
10/02/2014US20140294738 Treatment of rhinitis
10/02/2014US20140294737 Treatment of rhinitis
10/01/2014EP2783704A1 Pharmaceutical composition useful for adhesion prevention or hemostasis
10/01/2014EP2783687A1 Composition for inhibition of cathepsin K
09/2014
09/30/2014US8849441 Systems, devices, and methods for making or administering frozen particles
09/30/2014US8846947 Benzimidazoles and related analogs as sirtuin modulators
09/30/2014US8846931 Bipyridyl derivatives
09/30/2014US8846918 Compounds useful as inhibitors of ATR kinase
09/30/2014US8846910 Matrix metalloproteinase inhibitors
09/30/2014US8846763 High purity 2-[4-(3- or 2-fluorobenzyloxy)benzylamino] propanamides and methods of use thereof
09/30/2014US8846758 Methods of decreasing glycosylated hemoglobin in patients with dyslipidemia
09/30/2014US8846735 Compounds, compositions and methods for treating or preventing pneumovirus infection and associated diseases
09/30/2014US8846732 Inhibition of biogenic sulfide production via biocide and metabolic inhibitor combination
09/30/2014US8846726 Modulators of indoleamine 2,3-dioxygenase and methods of using the same
09/30/2014US8846725 Highly penetrating compositions and methods for treating pathogen-induced disordered tissues
09/30/2014US8846715 (2S,3R)-N-(2((3-pyridinyl)methyl)-1-azabicyclo[2.2.2]oct-3-yl)benzofuran-2-carboxamide novel salt forms, and methods of use thereof
09/30/2014US8846688 Sodium channel blockers
09/30/2014US8846686 Compounds useful as inhibitors of ATR kinase
09/30/2014US8846641 Stabilized ophthalmic galactomannan formulations
09/30/2014US8846638 Macrocyclic nucleoside phosphoramidate derivatives
09/30/2014US8846623 Cancer-targeting peptides and uses thereof in cancer treatment and diagnosis
09/30/2014US8846613 Pharmaceutical combinations for the treatment of metabolic disorders
09/30/2014US8846606 Method and drug composition for treating septic shock hypotension
09/30/2014US8846401 Promoters exhibiting endothelial cell specificity and methods of using same
09/30/2014US8846118 Use of anabolic agents, anti-catabolic agents, antioxidant agents and analgesics for protection, treatment and repair of connective tissues in humans and animals
09/30/2014US8846112 Methods of distributing a pharmaceutical product comprising nitric oxide gas for inhalation
09/30/2014US8846110 Polymeric systems for the delivery of anticancer drugs
09/30/2014US8846109 Treatment solution for treating wounds, in particular for liquid wound treatment
09/30/2014US8846098 Artificial cell constructs for cellular manipulation
09/30/2014US8846086 Tamper resistant dosage forms
09/30/2014US8846082 Probiotic and preservative uses of oil-emulsified probiotic encapsulations
09/30/2014US8846078 Brucellosis DNA vaccine
09/30/2014US8846074 Sublingual films
09/30/2014US8846030 Compounds and methods to enhance rAAV transduction
09/30/2014US8846029 Treatment of IBD and IBS using both probiotic bacteria and fermented cereal as treatment effectors
09/30/2014US8846024 3′-[(2Z)-[1-(3,4-dimethylphenyl)-1,5-dihydro-3-methyl-5-oxo-4H-pyrazol-4-ylidene]hydrazino]-2′-hydroxy-[1,1′-biphenyl]-3-carboxylic acid bis-(monoethanolamine)
09/25/2014WO2014153166A2 Therapeutic use of antibodies to hgf
09/25/2014WO2014153117A2 Antibodies to hgf and compositions containing
09/25/2014WO2014153087A1 Nanoparticle-based compositions
09/25/2014WO2014152635A1 Combination of direct acting antiviral agents and ribavirin for treating hcv patients
09/25/2014WO2014152629A1 Combination therapy to improve soft tissue healing, fat graft healing, endochondral bone healing and osteointegration
09/25/2014WO2014152564A1 Methods of acute restoration of vascular compliance
09/25/2014WO2014151180A1 Treatment of psoriatic arthritis using apremilast
09/25/2014WO2014151107A1 Wound healing compositions
09/25/2014WO2014150959A2 Method and products for enhancing cellular uptake of drug and dietary supplements
09/25/2014WO2014148646A1 Pluripotent stem cell for neuronal differentiation induction
09/25/2014WO2014148638A1 Aptamer to il-17 and use thereof
09/25/2014WO2014148438A1 Therapeutic agent for hepatitis c which comprises 4-(1,1,1,3,3,3-hexafluoro-2-hydroxypropan-2-yl)benzene derivative
09/25/2014WO2014148053A1 Use of ep4 receptor antagonists in the treatment of cartilage disease
09/25/2014WO2014147631A1 Formulation comprising gefitinib as oral suspension
09/25/2014WO2014147597A1 Aminofucoidan as a vector for fibrinolysis in thrombotic diseases
09/25/2014WO2014147353A1 Use of 4-{3-[cis-hexahydrocyclopenta[c]pyrrole-2(1h)-yl]propoxy}benzamide for treating neuropathic pain
09/25/2014US20140288623 Apparatus for treating cerebral neurovascular disorders including headaches by neural stimulation
09/25/2014US20140288347 Compounds useful as inhibitors of atr kinase
09/25/2014US20140288178 INHIBITION OF c-MYC UBIQUITINATION TO PREVENT CANCER INITIATION AND PROGRESSION
09/25/2014US20140288147 Methods of manipulating the fate of cells
09/25/2014US20140288142 Nitric oxide donor compounds
09/25/2014US20140288138 Angiotensin II Receptor Antagonist for the Prevention or Treatment of Systemic Diseases in Cats
09/25/2014US20140288126 Organic compounds
09/25/2014US20140288117 Use of cysteamine in treating parkinson's disease
09/25/2014US20140288115 Compositions and methods for treating brain cancer
09/25/2014US20140288112 8-azabicyclo[3.2.1]octane compounds as mu opioid receptor antagonists
09/25/2014US20140288102 Prevention of recurrences of urethral strictures following conventional therapy
09/25/2014US20140288095 Pyridopyrimidinone inhibitors of viruses
09/25/2014US20140288091 Mono-fluoro beta-secretase inhibitors
09/25/2014US20140288088 Inhibitors of the Renal Outer Medullary Potassium Channel
09/25/2014US20140288086 Enantiomerically pure aminoheteroaryl compounds as protein kinase inhibitors
09/25/2014US20140288059 Therapeutic compositions and methods
09/25/2014US20140288057 Method and composition for treating alzheimer-type dementia
09/25/2014US20140288047 Benzoxazepin pi3k inhibitor compounds and methods of use
09/25/2014US20140288040 Substituted benzylamine compounds, their use in medicine, and in particular the treatment of hepatitis c virus (hcv) infection
09/25/2014US20140288039 Lipobalanced long chain testosterone prodrugs for oral delivery
1 ... 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 ... 1151